`
`REVISED
`July 1999
`
`Release Society, Inc.
`
`An international socicty advancing the science and technology
`of chemical and btological delivery systems.
`
`PROCEEDINGS Book
`
` THE 26TH INTERNATIONAL SYMPOSIUM ON
`CONTROLLED RELEASE OF
`BIOACTIVE MATERIALS
`
`THE SECOND CONFERENCE ON
` CONSUMER AND
`
`DIVERSIFIED PRODUCTS
`
`a
`“hud
`
`Cs 74
`
`Gl
`
`49
`
`f Agnsel Kea
`
`
`
`June 20-25,1999
`
`
`PROGRAM COCHAIRS
`VLADIMIR ToRcHILIN, Northeastern University, USA
`FRANCESCO M. VERONESE, University of Padova,Italy
`
`June 20-23, 1999
`
`Proceed, Int'l Symp Control. Rel. Bloact.
`Mater. 26 (Revis
`+8
`July 1999)
`ISSN 1022-01 As
`Published by
`Controlled Release Society, Inc.
`
`Boston Marriott Copley PLACE, Boston, MA USA
`
`0001
`
`Noven Pharmaceuticals, Inc.
`EX2010
`Mylan Tech., Inc. v. Noven Pharma, Inc.
`IPR2018-00173
`
`
`
`
` #5123
`|
` Thia material may be protecled by Copyrght law (Tha 17 US. Coos)
`
`EFFECT OF SILICONE / ACRYLIC PSA BLENDS ON SKIN PERMEATION
`
`J.Mantelle', D. Kanios, S. Rossi-Montero, D. Houze, V. Nguyen, K. Moncada
`'Noven Pharmaceuticals, Inc., Miami, Florida 33186
`
`Introduction
`Rate and extent of skin permeation from
`drug-in-adhesive
`(DIA)
`transdermal
`drug
`delivery systems (TDDS) has traditionally
`been attributed solely to the barrier properties
`of the stratum corneum,a fact that has shed a
`negative light on the perceived ability of these
`DIA products to reproducibly attain the target
`pharmacological doses. Modification of these
`stratum corneum barrier properties has been
`sought by incorporation into these products of
`chemical enhancers such as fatty acids, esters,
`etc...alone or in combination with polyhydric
`alcohols. Although
`effective
`in
`skin
`permeations
`enhancement,
`chemical
`modification has a significant down side
`potential
`stemming
`from the
`increasing
`irritation potential
`that accompanies higher
`concentrations of these. Additionally, in DIA
`systems,
`these chemical enhancers typically
`possess
`surfactant
`properties
`_—‘tthat
`detrimentally affect
`the pressure sensitive
`adhesive (psa) properties of these and thus the
`wear properties of the finished product.
`
`Drug solubility modification via the blending
`of psa's has been shown to be as effective as
`chemical enhancement with the added benefit
`of having increased versatility in attainment
`of the required wear properties. PSA blends,
`and more specifically, blends of acrylic psa's
`with silicone psa's have been shown to afford
`the formulator the ability to manipulate the
`height of ‘the:
`initial delivery peak (burst
`effect), the lag time, and the length of time
`the product can sustain the pseudo-zero-order
`delivery of the permeant molecule. These
`performance characteristics are achieved by
`maximizing ‘thermodynamic driving force
`with the minimal drug content by
`
`manipulation of the silicone to acrylic psa
`ratio.
`
`Experimental Method
`Two different drugs were evaluated in order
`to demonstrate the effects of varying the
`silicone to acrylic psa ratio. The two drugs
`selected, selegiline and estradiol, were picked
`based on their differences. Selegiline base is a
`volatile liquid at room temperature whereas
`estradiol
`is a solid. Selegiline doses are
`targeted in the area of 5-10 mg/day whereas
`estradiol is targeted at 0.05-0.10 mg/day both
`from a 10 cm?patch area.
`
`The selegiline formulations were made at
`12% w/w drug while varying the acrylic psa
`content between 15 and 60% andthesilicone
`psa between
`28
`and 63%. No further
`excipients were used.
`
`The estradiol! formulations all contained 1.6%
`estradiol, 7.5% kollidon-30, 8% dipropylene
`glycol and 6% oleyl alcohol. The acrylic psa
`content was varied between 10 and 20% in
`conjunction with a silicone psa variation
`between 66.9 and 56.9% by weight in the
`finished product.
`
`The diffusion rate of the drug is determined
`through a disc of cadaver skin. Epidermal
`discs from the same donorand site were used
`in the study to factor out
`inter-subject
`variability in permeability.
`The receiving
`solution is an isotonic saline solution with a
`sodium azide preservative (0.9% NaCl and
`0.01% NaNs) with a pH of 6.7. The cell
`is
`kept at a constant temperature of 32 °C and
`stirred continuously at ~300 rpm.
`The
`number of replicate cells per formulation in
`
`Proceed. Int'l. Symp. Control. Rel. Blosct. Mater., 26 (Revised July 1999) Controlled Release Soctaty,Inc.
`
`0002
`
`
`
`the experiment was four. A known volume of
`saline was removed from the cell at specified
`time points. The complete contents of the
`receiver was removed and replaced with fresh
`saline to guard against solution saturation.
`The concentration of each sample ofsaline is
`determined through High Precision Liquid
`Chromatography with a detection wavelength
`of 220 nm.
`
`Results and Discussion
`SELEGILINE
`Figure #1 shows the effect of increased ratio
`of silicone to acrylic psa while holding the
`drug concentration constant at 12% drug. As
`can beseenin this plot, as the ratio ofsilicone
`to acrylic psa went from 28:60 to 58:30 to
`73:15,
`the
`corresponding
`average
`skin
`permeation rate went from 13.5 to 18.4 to
`29.7 ug/cm? with no significant changein the
`shape of the permeation curve (i.e.
`initial
`peak followed by a gradual fall off to the 26
`hour timepoint). Based on this performance,
`attaining equivalent rate and extent between
`the three formulations from a bioequivalence
`viewpoint could be achieved by varying the
`patch size.
`
`¢ tim 1 Oreetey
`Cheeses
`Sen ae
`=o 4/4)
`Oy) ere
`Kea Ne
`ST Oe.
`ie
`
`tran=:=
`BesregePum(ng/em
`
`
`#5123
`
`constant concentration of estradiol (1.6% by
`weight). As shown, varying the silicone to
`acrylic psa ratio from 56.9:20 to 61.9:15 to
`66.9:10 resulted in an average flux rate
`increase from 1.01 to 1.09 to 1.25 ug/cm’/hr
`with the additionaleffect of having altered the
`initial burst effect and subsequent sustenance
`of the pseudo-zero-order delivery profile. As
`can be seen in Figure 42, higher silicone to
`acrylic psa ratios resulted in a shift of the
`permeation profile from a pseudo-zero-order
`to a first order delivery system incapable of
`sustaining the targeted 84 hourdelivery.
`
`
`emits)=.=r.
`
`AverngePiss[n9/ey
`
`View (hey
`
`Figure 2 - Effect of Sillcome to Acrylic Ratio on Estradiol Flax
`
`Conclusion
`Alteration of thermodynamic driving force in
`a drug-in-adhesive transdermal drug delivery
`system by manipulation of pressure sensitive
`adhesive
`ratios
`in
`a
`blend of
`these,
`specifically silicone and acrylic psa's, can
`have a substantial effect on the rate and extent
`of skin permeation for selected molecular
`entities. By adjusting the ratio of these,
`the
`formulator
`is
`afforded
`a
`cost-effective
`alternative
`to
`permeation
`enhancement
`withoutthe deleterious effects on the physical
`and wear properties of the product which
`result from addition of large amounts of drug
`or surfactant-like channel enhancers,
`
`Acknowledgements
`To Dow corning Corporation and National
`Starch Companyfor their technica! support of
`our research and developmentprojects.
`
`A 2 on)
`
` ’ “
`
`Taek {howe
`
`Figure 1 - Effect of Silicone te Acrylic Ratio on Selegiline Flax
`
`ESTRADIOL
`Figure #2 illustrates the in-vitro performance
`of
`the
`estradiol
`formulations where
`the
`silicone to acrylic psa ratio was varied at a
`
`416
`
`Proceed. Int'l. Symp. Control. Rel. Bloact. Mater., 26 (Revised July 1999) Controlled Release Society,inc.
`Ps
`
`0003
`
`